Reta/Cag 12.5MG/2.5MG is a research compound that combines Retatrutide and Cagrilintide, developed for scientific studies in weight management and metabolic regulation.

Key Research Focus Areas:

• Dual-pathway approach to weight management through Retatrutide + Cagrilintide
• Investigation of appetite control, satiety, and energy balance
• Research into glucose regulation, insulin response, and overall metabolism